Kaida Wu

Kaida Wu, MD, Ph.D, currently serves as SVP and Head of Clinical Development at Cullinan Oncology since August 2022, having previously held the position of VP and Head of Clinical Development. Prior experience includes roles as Chief Medical Officer at GeneQuantum Healthcare, HOCT Early Clinical Development Head at Bristol Myers Squibb, and Executive Medical Director in various capacities at Celgene. Kaida's earlier career featured significant roles at The Janssen Pharmaceutical Companies of Johnson & Johnson, Sanofi, AstraZeneca, and Memorial Sloan-Kettering Cancer Center, where contributions to oncology and clinical research were notable. Educational credentials include a Postdoctoral Fellowship in Clinical Research from Memorial Sloan-Kettering Cancer Center, a Ph.D. in Clinical Medicine from Aarhus Universitet, and an MD in Hematology & Oncology from Southeast University, China.